6
total announcements
SMT.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 31 Oct 2026
Market Cap
₹4,703 Cr
P/E (TTM)
68.0
EPS (TTM)
₹6.80
52W Low
₹346.65
52W High
₹565.75
Dividend Yield
0.00%
Price / Book
6.4
Return on Equity
10.69%
Debt / Equity
49.4
Revenue (TTM)
₹1,211 Cr
Gross Margin
74.38%
Operating Margin
8.39%
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited has informed the Exchange about Schedule of Earnings Conference call to discuss the Q2 & H1FY27 financial results to be held on Thursday, November 05, 2026 at 06:30 p.m. (IST).
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited has received a summons under Section 70 of the Central Goods and Services Tax Act, 2017, for verification of books of accounts. The company is cooperating with the authorities and does not expect any material financial impact.
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited has informed the Exchange about the appointment of Ms. Deepshikha Singhal as the Company Secretary & Compliance officer, effective April 01, 2025.
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited has informed the Exchange regarding 'Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015'. The company has attached the 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' framed under Regulation 8(1) of the SEBI PIT Regulations.
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited has informed the Exchange regarding the authorized personnel for determining materiality of events or information and making disclosures to stock exchanges.
Sahajanand Medical Technologies Limited
Sahajanand Medical Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will remain closed from October 23, 2026, and will reopen after 48 hours from the declaration of the Un-Audited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30, 2026.